Table 1 |
|||||||
|
Clinical, endoscopic and histological features of all patients (n = 35). |
|||||||
|
No. |
Age |
Sex |
Other Diagnoses |
Duodenal Bulb |
Distal Duodenum |
||
|
(yrs) |
Gross Appearance |
Histology (Marsh type) |
Gross Appearance |
Histology (Marsh type) |
|||
|
|
|||||||
|
Group I |
|||||||
|
|
|||||||
|
1) |
12.5 |
M |
friability |
3b |
mosaic, scalloping |
3b |
|
|
2) |
3.7 |
M |
Type 1 diabetes |
normal |
1 |
normal |
3a |
|
3) |
1.8 |
M |
normal |
3c |
normal |
3c |
|
|
4) |
10.7 |
F |
Type 1 diabetes |
normal |
1 |
normal |
1 |
|
5) |
11.9 |
M |
normal |
3a |
mosaic, scalloping |
3a |
|
|
6) |
7 |
F |
edema |
3b |
mosaic, scalloping |
3b |
|
|
7) |
2.2 |
M |
normal |
3c |
mosaic, scalloping |
3b |
|
|
8) |
13.8 |
M |
Type 1 diabetes |
normal |
3a |
mild scalloping |
3a |
|
9) |
5.4 |
F |
erythema |
3a |
normal |
3a |
|
|
10) |
6.8 |
F |
normal |
3a |
mild scalloping |
3a |
|
|
11) |
2.5 |
F |
nodularity |
3b |
scalloping |
3b |
|
|
12) |
1.3 |
M |
normal |
3b |
mosaic, scalloping |
3b |
|
|
13) |
1.6 |
F |
normal |
3b |
mosaic |
3b |
|
|
14) |
10.3 |
M |
IgA nephropathy |
nodularity |
0 |
scalloping |
3b |
|
15) |
4.5 |
M |
normal |
3b |
nodularity, scalloping |
3b |
|
|
16) |
11.5 |
F |
Type 1 diabetes |
normal |
3b |
mosaic |
3b |
|
17) |
7.3 |
F |
normal |
2 |
erythema, scalloping |
2 |
|
|
18) |
7.2 |
F |
Down syndrome |
nodularity |
0 |
mosaic, scalloping |
3a |
|
19) |
18.8 |
M |
Type 1 diabetes |
nodularity |
3a |
mosaic, scalloping |
3a |
|
20) |
12.3 |
F |
nodularity |
3c |
mosaic, nodularity |
3c |
|
|
21) |
5.6 |
M |
normal |
3a |
mosaic, nodularity |
3a |
|
|
22) |
13.2 |
M |
nodularity, mosaic |
3c |
normal |
3b |
|
|
23) |
7.1 |
F |
Type 1 diabetes |
normal |
3c |
mosaic |
3c |
|
24) |
2.6 |
F |
normal |
3a |
scalloping |
3a |
|
|
25) |
1.8 |
F |
normal |
3c |
mosaic, scalloping |
3c |
|
|
26) |
5.4 |
M |
mosaic |
3c |
mosaic |
3a |
|
|
27) |
14.2 |
F |
mosaic |
3c |
scalloping |
3b |
|
|
28) |
11.1 |
F |
nodularity, mosaic |
3c |
scalloping |
3a |
|
|
29) |
9 |
F |
normal |
3a |
mosaic, scalloping |
3a |
|
|
30) |
17.7 |
F |
Type 1 diabetes |
normal |
3a |
mosaic |
3a |
|
31) |
10.1 |
F |
normal |
3b |
normal |
3b |
|
|
|
|||||||
|
Group II |
|||||||
|
|
|||||||
|
1) |
10.8 |
F |
Type 1 diabetes |
nodularity |
3a |
normal |
0 |
|
2) |
9.2 |
M |
mild erythema |
2 |
normal |
0 |
|
|
3) |
9.4 |
F |
mosaic |
3c |
normal |
0 |
|
|
4) |
4.6 |
F |
normal |
3c |
normal |
0 |
|
|
|
|||||||
|
All patients had a positive TTG antibody. |
|||||||
|
Rashid and MacDonald BMC Gastroenterology 2009 9:78 doi:10.1186/1471-230X-9-78 |
|||||||
